Investigational Site Number :6200005

Almada 2801-951

0 studies enrolling now · 2 studies all time

What they study most

Asthma, Breast Cancer, Chronic Rhinosinusitis With Nasal Polyps

Studies at this site

• EValuating trEatment RESponses of Dupilumab Versus Omalizumab in Type 2 Patients — Completed
• Amcenestrant (SAR439859) Plus Palbociclib as First Line Therapy for Patients With ER (+) HER2(-) Advanced Breast Cancer — Stopped early